Riskpilot← Back to searchSign inGet full accessFAABORG PHARMA A/S
A/SActiveCVR 26190770Markedspladsen 13A, 1.Manufacture of perfumes and toilet preparations · NACE 2042Est. 200118 employeeswww.faaborgpharma.dk
Revenue 2024
DKK 10,9M
+3% vs 2023
EBITDA margin
32.1%
+3% vs 2023
Equity ratio
42.7%
Financial strength
Net profit 2024
DKK 1,8M
+9% vs 2023
| Revenue | DKK 10,9M | +3% |
| EBITDA | DKK 3,5M | +3% |
| Net profit | DKK 1,8M | +9% |
| Total assets | DKK 22,8M | +25% |
| Equity | DKK 9,8M | +22% |
| Employees | 18 | — |
Legal name
FAABORG PHARMA A/S
CVR number
26190770
Legal form
Aktieselskab
NACE code
2042 · Manufacture of perfumes and toilet preparations
Founded
15. august 2001
Share capital
DKK 1.000.000
Employees
18 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren og bestyrelsesformanden
i forening, eller af den samlede bestyrelse
Company purpose
Selskabets formål er fabrikation og handel samt anden hermed beslægtet virksomhed.
Address
Markedspladsen 13A, 1.
Phone
+4538415050
Email
info@faaborgpharma.dk
Website
www.faaborgpharma.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.848 | 2.864 | 4.269 | 2.038 | 5.352 | 4.569 | 6.798 | 6.457 | 11.292 | 6.980 | 10.328 | 10.602 | 10.880 |
| Staff expenses | -4.439 | -4.127 | -2.711 | -2.770 | -2.621 | -3.067 | -3.124 | -4.349 | -4.973 | -5.759 | -7.057 | -7.212 | -7.385 |
| EBITDA | -1.591 | -1.263 | 1.558 | -732 | 2.731 | 1.502 | 3.674 | 2.108 | 6.265 | 1.118 | 3.270 | 3.391 | 3.494 |
| Depreciation & amort. | -361 | -452 | -367 | -442 | -432 | -548 | -652 | -897 | -961 | -891 | -1.085 | -1.059 | -959 |
| EBIT | -1.952 | -1.716 | 1.191 | -1.175 | 2.299 | 955 | 3.022 | 1.211 | 5.305 | 227 | 2.185 | 2.332 | 2.535 |
| Net financials | -286 | -362 | -590 | -616 | -583 | -433 | -306 | -291 | -177 | -189 | -165 | -298 | -291 |
| Profit before tax | -2.238 | -2.078 | 601 | -1.791 | 1.715 | 521 | 2.716 | 921 | 5.127 | 37 | 2.020 | 2.034 | 2.244 |
| Tax | -583 | -353 | 123 | -410 | 473 | 11 | 603 | 208 | 1.136 | 6 | 461 | 424 | 481 |
| Net profit | -1.654 | -1.725 | 478 | -1.381 | 1.242 | 510 | 2.114 | 713 | 3.992 | 31 | 1.559 | 1.611 | 1.763 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5.720 | 6.863 | 7.215 | 7.196 | 7.106 | 7.448 | 8.239 | 10.397 | 14.355 | 14.652 | 18.317 | 18.252 | 22.823 |
| Equity | -1.150 | -2.875 | -2.397 | -3.778 | -2.536 | -2.026 | 88 | 801 | 4.793 | 4.824 | 6.383 | 7.994 | 9.757 |
| Long-term debt | 797 | 708 | 5.665 | 4.532 | 2.998 | 1.442 | 612 | 1.723 | 1.496 | 1.096 | 2.060 | 1.629 | 1.393 |
| Short-term debt | 6.072 | 9.030 | 3.946 | 6.442 | 6.643 | 8.032 | 7.442 | 7.615 | 7.855 | 8.420 | 9.433 | 8.191 | 11.248 |
| Total debt | 6.870 | 9.738 | 9.611 | 10.974 | 9.641 | 9.474 | 8.054 | 9.338 | 9.351 | 9.517 | 11.493 | 9.820 | 12.642 |
EBITDA margin
32.1%
This company
15.8%
Market median
+103% vs market
20122024
Equity ratio
42.7%
This company
38.2%
Market median
+12% vs market
20122024
Return on equity
18.1%
This company
18.4%
Market median
+2% vs market
20122024
Net profit margin
16.2%
This company
8.1%
Market median
+100% vs market
20122024
Asset turnover
0.48×
This company
1.12×
Market median
-57% vs market
20122024
Debt / equity
1.34×
This company
0.62×
Market median
-116% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
FH Management | Management | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2010 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2010 | — | — | |
| Chairman | 2016 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Faaborg Løve Produkter Holding I ApS | Company | 100.0% | 100.0% | 2022 |
Jonas Rössing Holding ApS | Company | 10.0% | 10.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
FAABORG LØVE PRODUKTER HOLDING ApSFaaborg Løve Produkter Holding I ApS
FAABORG PHARMA A/S (this company)Board members of FAABORG PHARMA A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Frank Hauken Vibæk | Management | 0 companies |
| Jonas Rössing | Board of Directors | 0 companies |
| Pernille Rosager Nielsen | Board of Directors | 0 companies |
| Birk Simon Maldonado Andersen | Board of Directors | 0 companies |
| Sten Grønved Nielsen | Chairman | 0 companies |
| Jan Knudsen | Board of Directors | 0 companies |
| Birthe Susanne Bisgaard | Board of Directors | 0 companies |
| Claus Wædeled | Chairman | 0 companies |